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A B S T R A C T
Background: There is growing interest in the provision of parenting support to substance misusing parents.
Methods: This pragmatic, multi-center randomized controlled trial compared an intensive one-to-one parenting
program (Parents under Pressure, PuP) with Treatment as Usual (TAU) in the UK. Parents were engaged in
community-based substance misuse services and were primary caregivers of children less than 2.5 years of age.
The primary outcome was child abuse potential, and secondary outcomes included measures of parental emo-
tional regulation assessed at baseline, 6 and 12-months. A prospective economic evaluation was also conducted.
Results: Of 127 eligible parents, 115 met the inclusion criteria, and subsequently parents were randomly as-
signed to receive PuP (n= 48) or TAU (n= 52). Child abuse potential was signiﬁcantly improved in those
receiving the PuP program while those in TAU showed a deterioration across time in both intent-to-treat
(p < 0.03) and per-protocol analyses (p < 0.01). There was also signiﬁcant reliable change (recovery/im-
provement) in 30.6% of the PuP group compared with 10.3% of the TAU group (p < 0.02), and deterioration in
3% compared with 18% (p < 0.02). The probability that the program is cost-eﬀective was approximately 51.8%
if decision-makers are willing to pay £1000 for a unit improvement in the primary outcome, increasing to 98.0%
at a £20,000 cost-eﬀectiveness threshold for this measure.
Conclusions: Up to one-third of substance dependent parents of children under 3-years of age can be supported to
improve their parenting, using a modular, one-to-one parenting program. Further research is needed.
1. Introduction
An increasing body of research suggests that adverse outcomes for
children raised in families with parental substance-misuse emerge early
in the child’s life and are related to the quality of the parent-child re-
lationship that signiﬁcantly impacts on the child’s developing neuro-
logical (Schore, 2010) and attachment (De Wolﬀ and van Ijzendoorn,
1997) systems (see Hatzis et al., 2017 for a review). Importantly, the
quality of the caregiving relationship is itself impacted by numerous
chronic and inter-related problems that include co-occurring psychia-
tric disorders, particularly disorders of aﬀect regulation (Taylor et al.,
1997), depression (Dix et al., 2004), and borderline personality dis-
order (Petﬁeld et al., 2015). Increasingly, families with multiple and
complex needs, which include parental substance misuse, have become
the primary client group of child protection systems across the world
(Bromﬁeld et al., 2012). Supporting such families requires early inter-
ventions that reduce the risk of child maltreatment by enhancing the
quality of caregiving, provision of knowledge and skills around par-
enting and child development, and reducing maternal risk factors that
include dysregulated aﬀect.
1.1. Evidence supporting interventions for parents with substance abuse
problems
A number of recent studies evaluating interventions for substance
misusing parents have extended beyond a focus on parenting skills to
address the factors that erode the capacity for sensitive parenting in-
cluding parental emotional dysregulation. For example, Dakof et al.
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(2010) compared the Engaging Moms Program (EMP) with Intensive
Case Management Services (ICMS) in a pilot study carried out in the
context of the Family Drug Court. The authors reported large eﬀect
sizes on a range of outcome measures and suggested the intervention
was promising despite the lack of statistical signiﬁcance. Suchman and
colleagues (Suchman et al., 2010, 2017) developed an attachment-
based intervention (Mothering from the Inside Out, MIO) aimed at
enhancing a mother’s capacity to make sense of her own and her child’s
mental state. Two randomized controlled trials found improvements in
maternal reﬂective functioning at three months (Suchman et al., 2010,
2017), with mothers who received MIO also showing signiﬁcantly
greater sensitivity and reciprocity on observational measures of mother-
child interactions at 12-months. Two studies have evaluated interven-
tions with parents in residential treatments that address trauma-related
attachment patterns of parents with the goal of improving the parent-
child relationship. In a small group of mothers (N= 21) Berlin et al.
(2014) found their intervention increased sensitive parenting behavior.
(Paris et al., 2015) found that mothers reported a decrease in psycho-
logical distress, with the greatest decrease reported by mothers initially
displaying the highest level of psychological distress.
1.2. The Parents under Pressure (PuP) Program
The PuP program was speciﬁcally developed for complex families
facing multiple adversities, including parental substance misuse and
psychopathology, socioeconomic challenges and either potential or
current involvement in the child protection system. While there are
many challenges for such families, one key characteristic of people with
substance abuse is dysregulated aﬀect that underpins impulsive beha-
vior (Dawe and Loxton, 2004). For parents, this results in an inability to
manage emotions both within the context of parenting and in other
areas of everyday living. Parents with poor emotional regulation show
less attunement to their child, can be harsh and have little aﬀective
sensitivity, factors associated with compromised infant and child de-
velopment (e.g., Martinez-Torteya et al., 2014), and child abuse po-
tential (Smith et al., 2014). Helping parents enhance their capacity for
emotional regulation is addressed in the PuP program through the use
of mindfulness strategies to support mindful parenting. A randomized
controlled trial in Australia of parents on methadone maintenance
compared the PuP program with a brief behavioral parenting inter-
vention and standard care (Dawe and Harnett, 2007) in children aged
four years. Signiﬁcant gains were found in self-reported child abuse
potential, depression anxiety and stress, parenting stress and child be-
havior. A recent quasi-experimental study of a pre-birth risk assessment
process compared a pre-birth risk assessment plus PuP to usual care in
expectant mothers (Harnett et al., 2018). The pre-birth risk assessment
process resulted in a greater number of removals at birth. Of those
mothers who retained the care of their infants, 42% receiving the PuP
program had improved child protection outcomes at 12-months com-
pared to 14% of infants in routine care. The PuP program has also been
evaluated in a series of single case studies of parents on methadone
maintenance (Dawe et al., 2003), women leaving prison (Frye and
Dawe, 2008) and families engaged in the child protection system
(Harnett and Dawe, 2008).
1.3. Aims of the current study
The primary aim of the current study was to evaluate the PuP
program with parents currently engaged in community-based substance
abuse treatment. This study builds on the eﬃcacy trial (Dawe and
Harnett, 2007) to determine eﬀectiveness and cost-eﬀectiveness of the
PuP program when delivered by front-line practitioners in community
settings with a heterogeneous sample of parents engaged in substance
abuse treatment services. Thus, this pragmatic, randomized controlled
trial balanced the elements of an eﬃcacy trial such as randomization
and clearly deﬁned treatment duration with elements of an
eﬀectiveness trial that included referral from a range of treatment
agencies with the PuP program deliverd by existing practitioners
(Marchand et al., 2011). This balance of internal and external validity is
proposed to provide an optimal test of the intervention under real-
world conditions.
2. Methods
2.1. Study design and randomization
This was a pragmatic, randomized controlled trial comparing the
PuP program to Treatment as Usual (TAU) for parents who were cur-
rently engaged in substance misuse treatment services. A 1:1 computer-
generated randomization sequence stratiﬁed by treatment site was
implemented with minimization, using R (R Core Team, 2017). Parti-
cipating parents were randomly assigned to either the PuP program or
TAU by an independent researcher. Assessments were conducted at
baseline, 6 and 12-months as the time to completion of the PuP pro-
gram was approximately 6-months. Parents received a £20 gift voucher
at each assessment point. The study was granted ethical approval from
the Biomedical Research Ethics Committee at the University of War-
wick (BREC reference number 189-03-2012).
2.2. Participants and procedure
Participants were parents who were receiving treatment for a drug
or alcohol problem (opioid replacement treatment, relapse prevention,
counseling) and were a primary carer of a child under the age of 2.5
years. If both parents had an alcohol or drug problem, the primary
caregiver was assessed. Exclusion criteria were: (i) the infant was not
currently residing with primary carer and there were no plans for re-
uniﬁcation, (ii) pregnant women (unless the baby was due within 4
weeks of the recruitment period) (iii) women who reported that being
in a relationship in which there was active and ongoing domestic abuse,
or (iv) were actively psychotic or expressing active suicidal ideation.
2.3. Study recruitment
Study recruitment took place between October 2014 and December
2016 at seven participating centers. Following consent from parents,
the research team then contacted the parent, who completed the re-
cruitment process including obtaining written consent, and baseline
data. Data were collected by a researcher who was blind to study arm
and randomization occurred post baseline interview (Fig. 1, Study ﬂow-
chart).
2.4. Interventions: parents under Pressure
The PuP program was developed to address multiple domains of
family functioning with the goal of reducing child abuse potential by
enhancing parental emotional regulation (Dawe and Harnett, 2007;
Harnett et al., 2018). The PuP program is underpinned by the In-
tegrated Theoretical Framework (ITF) which is a dynamic model of
assessment and treatment planning drawing from attachment theory,
behavioral parenting skills, and adult psychopathology (see Barlow
et al., 2016). The ITF provides a structure to assess the quality of car-
egiving relationship, parenting practices, values and expectations and
the parent’s capacity for emotional regulation with consideration given
to the impact of the wider ecological context of the family. Speciﬁc
targets for change are identiﬁed during the assessment, which then
becomes the focus of treatment. There are twelve modules, and each
comprises a theme that can continue throughout treatment. While each
treatment plan is individualized, all cases include a focus on the quality
of caregiving and parental emotional regulation. For example, Module
6, Connecting with Your Baby or Child provides structure and a series of
activities whereby a parent is able to reﬂect on their own relational
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experience with their infant or child. There is an emphasis on learning
their baby’s language and ‘mindful play’ in which a parent is taught to
use mindfulness constructs to observe, describe and participate during
play and at special times. Module 4, How to Manage Your Emotions
Under Pressure: Increasing Mindful Awareness provides opportunities for
parents to reﬂect on their ability to manage mood and impulsive be-
haviors through the incorporation of mindfulness-based strategies. The
use of the remaining modules depends on the identiﬁed needs and case
formulation. For example, the Relationship module includes a focus on
improving communication in intimate relationships. It also includes
sections on deﬁning the qualities of a good and loving intimate re-
lationship for couples with a troubled relationship history while the
module on Managing Substance Use Problems focuses on both remaining
abstinent and managing lapses. The PuP program was delivered in fa-
mily homes with additional visits to support case management as ap-
propriate.
Fourteen practitioners in family centers delivered the PuP program.
Of these, eight held formal qualiﬁcations in social work; the remaining
had previous experience in family support work. All practitioners were
Accredited PuP therapists having received a minimum of 40 h of
training and supervision in the PuP model and had completed accred-
itation requirements. Ongoing monthly clinical supervision was pro-
vided during the study period and six-monthly development days took
place where workshops were provided in related topics led by either the
PuP training team or outside experts (e.g., a workshop on mindfulness).
2.5. Interventions: treatment as usual
TAU provided the opportunity to compare the PuP program with
established services across a range of sites. As in other studies of this
population, (e.g., Donohue et al., 2014) no attempt was made to stan-
dardize TAU in keeping with the principles of pragmatic trials and
thereby allowing for the comparison of outcomes to real-world service
conﬁgurations. The referral agencies had a range of services available
that included family support, family counseling, and parenting pro-
grams provided in a group format.
Fig. 1. Consolidated Standards of Reporting Trials (CONSORT) study diagram.
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2.6. Treatment dose and adherence
Program dose and retention were monitored through the collection
of information about session number and duration (weeks) of engage-
ment in the PuP program. Supervision was provided and the number of
supervision hours each practitioner received was recorded. Adherence
to the PuP model was assisted by the provision of a Therapist Manual
and Parent Workbook and further assessed by indepenent case ﬁle au-
dits conducted by a senior practitioner not invovled in treatment de-
livery to ensure that practitioners were using key elements of the PuP
program.
2.7. Measures
Baseline demographics included the history of substance use, cur-
rent treatment and recent use in the last 30-days (Timeline Follow-Back
Interview; Fals-Stewart et al., 2000). Concordance between TLFB and
head hair (sample length 3 cm) was obtained from a random sample of
10 (10%) participants, and percentage concordance between hair
sample and TLFB (baseline) for amphetamine, cannabis, cocaine, me-
thadone, and other opioid was calculated (Sharma et al., 2016). Parents
completed the Severity of Dependence Scale (Gossop et al., 1995) for
the primary substance of use and the HITS (Sherin et al., 1998), to
obtain parent report of involvement in domestic violence.
The primary outcome measure was the Risk Abuse Scale from the
Brief Child Abuse Potential Inventory (BCAP; Ondersma et al., 2005)
with a threshold of greater than or equal to 12 to indicate risk of child
abuse. The BCAP has been validated across a range of populations,
including mothers on opioid substitution therapy (Dawe et al., 2016).
Secondary outcomes assessed parental emotional regulation, psycho-
pathology and parenting stress using the following measures: Diﬃcul-
ties in Emotional Regulation Scale (DERS; Gratz and Roemer, 2004;
Neumann et al., 2010), Personality Assessment Inventory-Borderline
Scale (PAI-BOR; Gardner and Qualter, 2009; Morey, 1991; Trull et al.,
Table 1
Baseline characteristics of parents.
Parent Variable PuP
n=52
TAU
n=48
t-test or χ2 Total
(n=100)
Age in years (mean, sd) 30.6 (5.6) 31.0 (5.2) t=.76 30.8 (5.4)
Sex (%) Male 3 (5.8) 1 (2.1) χ2=0.8 4
Marital status (%) Married/Cohabiting 21 (40.4) 17 (35.4) χ2=1.1 38
Other 4 (7.7) 6 (12.5) 10
Separated 1 (1.9) 1 (2.1) 2
Single 26 (50.0) 24 (50.0) 50
Self-reported Ethnicity (%) White British 42 (80.8) 44 (91.7) χ2=2.7 86
Other ethnicity* 7 (13.5) 2 (4.2) 9
Missing/refused 3 (5.8) 2 (4.2) 5
Education level (%) GCSE or below 23 (44.2) 25 (52.1) χ2=2.5 48
A-levels 6 (11.5) 3 (6.2) 9
Higher Education 5 (9.6) 2 (4.2) 7
Other 15 (28.9) 17 (35.4) 32
Missing 3 (5.7) 1 (2.1) 4
Main income (%) Paid employment 2 (3.8) 2 (4.2) χ2=1.8 4
Income Support/ Disability allowance 9 (17.3) 4 (8.3) 13
Unemployment beneﬁt/ Single parent allowance 41 (78.8) 42 (87.5) 83
Domestic violence† (%) Positive risk (> 10 points) 6 (11.5) 8 (17.7) χ2=0.3 14
Negative risk (≤10 points) 37 (71.2) 36 (75.0) 73
Missing** 9 (3.8) 4 (8.3) 13
Criminal record (%) Yes, ever 26 (50.0) 25 (52.1) χ2=<0.1 51
Yes, within last 12 months 10 (19.2) 7 (14.6) χ2=1.5 17
Alcohol
Non-prescribed opioid
Prescribed opioid
Cocaine
Cannabis
12 (23.1)
3 (5.8)
30 (57.7)
1 (1.9)
6 (11.5)
16 (33.3)
0 (0)
24 (50.0)
3 (6.3)
5 (10.4)
χ2=5.2 28 (28.0)
3 (3.0)
54 (54.0)
4 (4.0)
11 (11.0)
Opioid Replacement dose Methadone
(n=38)
47.5 (18.8 48.6 (24.4) t =-153 48.05 (21.2)
SDS score SDS current
% scoring > 4
6.91 (3.4)
78.3
7.16 (4.2)
70.5
t =-0.3 7.03 (3.8)
74.6
Substance use in last 30 days (TLFB)
Days of alcohol use (%) 0 use
1 – 5 days
6 – 15 days
16 – 30 days
63.5
30.8
1.9
3.8
79.2
18.8
2.1
0.0
χ2=4.2 71.0
25.0
2.0
2.0
Days of non-prescribed opioid use (%) 0 use
1 – 5 days
6 – 15 days
16 – 30 days
82.7
9.6
5.8
1.9
89.6
10.4
0.0
0.0
χ2=3.9 86.0
10.0
3.0
1.0
Days of cannabis use (%) 0 use
1 – 5 days
6 – 15 days
16 – 30 days
86.5
1.9
0.0
11.5
87.5
2.1
2.1
8.3
χ2=1.4 87.0
2.0
1.0
10.0
Days cocaine use (%) 0 use
1 – 5 days
6 – 15 days
16 – 30 days
92.3
5.8
1.9
0.0
89.6
8.3
2.1
0.0
χ2=0.3 91.0
7.0
2.0
0.0
*Other ethnicity includes responses not clearly White British, e.g., “Jamaican White”, “Scottish”.
†Scored using HITS - Fam Med 1998;30(7):508-12.
**At least one item not answered.
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2006), the Depression, Anxiety and Stress Scale (DASS; Lovibond and
Lovibond, 1995aa, 1995b), and the Parenting Stress Index short form
(PSI-SF; Abidin, 1995). Infant outcomes were measured using the Brief
Infant and Toddler Socio-emotional Adjustment Scale (BITSEA; Briggs-
Gowan et al., 2004) for infants aged 12 – 36-months. Parent-infant/
toddler interaction was assessed using the CARE-Index (Crittenden,
2006).
2.8. Statistical analyses and power calculation
Sample size was based on eﬀect sizes obtained in Dawe and Harnett
(2007) using the Child Abuse Potential Inventory (CAPI; Milner, 1986)
where an eﬀect size (ES) of 0.92 was obtained. As the current study was
conducted as an eﬀectiveness study, a smaller eﬀect size was expected
(Marchand et al., 2011). Hence, to detect an eﬀect size (ES) of ap-
proximately 0.5 at 80% power and 5% signiﬁcance, 54 parents would
be required in each arm, and 57 in each arm allowing for dropout in the
region of 5% (a total of 114 parents). Recruitment was slower than
anticipated and was closed at 100 parents. With the smaller than an-
ticipated sample and an observed loss to follow up of 10%, calculations
estimated 70% power for an ES of 0.5 or 80% power at an ES of 0.55.
All analyses were undertaken using Statistical Package for the Social
Sciences, SPSS version 22.0 and R. To adjust for loss to follow-up, data
were multiply imputed (van Buuren and Groothuis-Oudshoorn, 2011)
for the primary outcome measure (BCAP). Both intent-to-treat and per-
protocol analyses were conducted given the smaller sample size and an
attrition rate that exceeded 20% (Nich and Carroll, 2002; ICH
Harmonised Tripartite Guidelines, 1998). The intent-to-treat analysis
conducted on total scales used multi-level modeling (MLM; Bates et al.,
2015) of outcomes for each participant with allocation group and
follow-up point treated as ﬁxed eﬀects and a random eﬀect added for
each participant. P-values were calculated using the Satterthwaite ap-
proximation of the F-distribution. The per-protocol analyses were
conducted on total scales using repeated measures Analysis of Variance
on cases receiving three or more sessions and retained in the study to
12-months.
To establish if changes for the BCAP outcome were clinically
meaningful, the Reliable Change Index (RCI; Jacobson and Truax,
1991) was calculated for each parent from baseline to 12-months. An
individual score was determined to be clinically signiﬁcant if the RCI
index was greater than 1.96 and subsequently classiﬁed as improved/
recovered, no change or deteriorated. Change in clinical risk status was
also calculated with positive risk abuse set at greater than or equal to 12
(Ondersma et al., 2005).
2.9. Economic evaluation
A within-trial economic evaluation was conducted from the re-
commended UK NHS and personal social services perspective (National
Institute for Health and Care Excellence, 2013). This involved the
identiﬁcation, measurement and valuation of costs and consequences in
both trial arms over the trial time horizon to estimate the additional
costs and beneﬁts associated with the PuP program and synthesizing
those estimates within cost-eﬀectiveness ratios. Program costs were
estimated primarily by PuP practitioners completing detailed weekly
activity logs outlining the number, type and duration of contacts with
families, and with professionals that provided supervision or support,
and associated administrative activities, and the type and cost of con-
sumables and other PuP-related expenses. Broader resource utilization
was captured through interviewer-administered questionnaires com-
pleted at baseline and at each follow-up point and provided proﬁles of
hospital and community health and social services received by each
parent-child dyad. Information was also collected regarding the use of
legal services and costs borne directly by parents. Unit costs (£, 2016
prices) were collected from national sources in accordance with
guidelines and attached to resource inputs. The EuroQol EQ-5D-5 l
(Herdman et al., 2011) health-related quality of life questionnaire was
completed by parents at baseline and at each follow-up point; responses
were used to estimate quality-adjusted life year (QALY) proﬁles for
each parent, calculated as area under the baseline-adjusted utility
curve, assuming linear interpolation between utility measurements.
Cost-eﬀectiveness results are reported as incremental cost-eﬀectiveness
ratios (ICERs), calculated as the diﬀerence in mean costs divided by the
diﬀerence in mean outcomes (QALYs or BCAP) between the trial
comparators. Bootstrapped bivariate regression was used to model
within-trial incremental changes in costs and QALYs, with multiple
imputed models summarized using Rubin’s rule (Rubin, 2004). Cost-
eﬀectiveness acceptability curves (CEACs) showing the probability that
the PuP program is cost-eﬀective relative to TAU across a range of cost-
eﬀectiveness thresholds were also generated, based on the proportion of
bootstrap replicates with positive incremental net beneﬁts. Several
sensitivity analyses were undertaken as follows: (1) adopting a wider
societal perspective; (2) restricting the analyses to complete cases; and
(3) recalculating the average cost per PuP session by applying either: (i)
the highest mean cost per session estimated across all sites; or (ii) the
lowest mean cost per session estimated across all sites.
3. Results
3.1. Participant characteristics
There were no signiﬁcant diﬀerences in baseline characteristics of
parents allocated to the two groups. The majority of parents were
mothers (96%), with a mean age of 30.8 years. Tables 1 and 2 present
Table 2
Baseline characteristics of children.
Child Variable PuP
(n= 52)
TAU
(n= 48)
t-test or χ2 Total
(n= 100)
Age in months (mean1, sd) 9.8 (878) 8.6 (9.7) t=0.7 9.2 (9.1)
Sex
Female 21 (40.4) 18 (37.5) χ2=1.1 39
Male 30 (57.7) 30 (62.5) 60
Missing 1 (1.9) 0 (0) 1
Child lives with:
Mother 50 (96.2) 42 (87.5) χ2=2.5 92
Not with Mother 2 (3.8) 6 (1254) 8
Has siblings - Yes (n, %) 43 (82.7) 36 (75.0) χ2=0.9 79
Child currently involved in
child protection - Yes (n, %)
40 (80.0) 42 (87.5) χ2=1.0 82
Child previously involved in
child protection - Yes (n, %)
13 (26.5) 12 (25.0) χ2=0.03 25
Other children involved in child
protection - Yes (n, %)
36 (72.0) 29 (61.7) χ2=1.2 65
1One parent was still pregnant at baseline.
Table 3
BCAP scores by group at assessment; 6 months and 12 months.
Time point Value PuP TAU
Baseline Score (mean, sd) 9.3 (5.6) 8.8 (5.7)
Positive for abuse
(n, % valid)
19 (36.5) 17 (35.4)
No. valid (n, % of group) 52 (100) 48 (100)
Post intervention Score (mean, sd) 7.0 (5.7) 8.8 (6.4)
Positive for abuse
(n, % valid)
9 (21.4) 18 (41.9)
No. valid
(n, % of group)
42 (80.8) 43 (89.6)
Final follow up Score (mean, sd) 7.3 (5.8) 9.8 (5.7)
Positive for abuse
(n, % valid)
8 (22.2) 16 (41.0)
No. valid
(n, % of group)
36 (69.2) 39 (81.8)
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data on demographic and substance use measures. There was high
concordance between hair sample toxicology and TLFB for ampheta-
mines, benzodiazepines, cannabis, cocaine and non-prescribed opioids
(100% – 70%). However, there was low concordance for methadone
(50%) with a high rate of over-reporting by participants.
3.2. Program dose, retention and ﬁdelity
The mean number of days of engagement in the PuP program from
date of consent was 122 (SD=122); the mean number of sessions
delivered was 11.1 (SD=8.19). Sixty-eight percent of parents com-
pleted six or more sessions. The mean number of supervision hours
Table 4
MLM of total scores over time by group with interaction.
Variable Estimate Lower
95% CI
Upper
95% CI
p-value
BCAP
Allocation group
(Reference=PuP)
TAU −0.5 −2.7 1.8 0.13
Time Point Post intervention −2.5 −4.2 −0.7
Final follow up −2.2 −4.2 −0.3
Interaction eﬀect TAU×Post intervention 2.5 0.3 5.0 0.03*
TAU× ﬁnal follow up 3.3 0.7 5.9
DERS
Allocation group
(Reference=PuP)
TAU −1.3 −11.4 8.8 0.05
Post intervention −12.5 −19.7 −5.3 0.16
Final follow up −10.1 −17.7 −2.4
Interaction eﬀect TAU×Post intervention
TAU x ﬁnal follow up
15.2
14.5
5.0
3.8
25.3
25.1
.005*
DASS Total
Allocation group
(Reference=PuP)
TAU 1.2 −11.0 13.2 0.09
Post intervention −9.3 −18.1 −0.5 0.18
Final follow up −10.6 −19.0 −2.2
Interaction eﬀect TAU×Post intervention
TAU x ﬁnal follow up
13.6
10.0
1.3
−1.8
25.9
21.8
0.07
PSI Total
Allocation group
(Reference=PuP)
TAU −2.3 −12.0 7.3 0.31
Post intervention
Final follow up
3.5
4.7
−5.6
−4.9
12.7
14.4
0.45
Interaction eﬀect TAU×Post intervention
TAU x ﬁnal follow up
3.5 −5.6 12.7 0.68
PAI BOR Total
Allocation group
(Reference=PuP)
TAU 0.3 −4.3 4.8 0.11
Post intervention −4.0 −7.4 −0.6 0.22
Final follow up −2.9 −6.5 0.6
Interaction eﬀect TAU×Post intervention
TAU x ﬁnal follow up
3.9
4.7
−0.9
−0.3
8.6
9.7
0.13
Table 5
Per protocol analysis of parents receiving PuP (n=36) and TAU (n=39).
Measure Group Baseline Post Follow-up Group x Time interaction F value
(ηp
2)1
Planned Contrasts
paired t-test; t
(cohen’s d)2
Mean (SD) Mean (SD) Mean (SD) Baseline vs
6 months
6 vs 12 months Baseline
vs
12 months
BACP PUP 10.2 (5.6) 6.4 (5.5) 7.3 (5.8) 6.85** (0.09) 2.43* (0.69) −1.21 (0.16) 2.54* (0.51)
TAU 8.4 (5.6) 8.8 (6.5) 9.8 (5.7) −0.09 (0.07) −1.16 (0.16) −1.57 (0.24)
DERS PUP 91.5 (30.8) 74.3 (24.9) 78.5 (26.6) 6.77** (0.09) 3.50** (0.69) −1.35 (0.16) 2.84* (0.45)
TAU 86.1 (28.0) 87.8 (25.8) 90.2 (22.3) −0.63 (0.06) −0.68 (0.10) −1.00 (0.16)
DASS-42 PUP 36.6 (33.2) 19.8 (25.1) 24.4 (29.9) 4.83* (0.06) 1.99 (p= .05) (0.57) −1.37 (0.17) 2.18* (0.39)
TAU 34.3 (32.2) 34.4 (32.3) 39.2 (31.4) 0.06 (0.00) −1.27 (0.15) −1.05 (0.15)
PSI_Total PUP 74.4 (24.3) 61.9 (20.7) 61.6 (19.3) 2.84; p= .06 (0.04) 3.50 ** (0.55) 0.07 (0.02) 3.07** (0.58)
TAU 70.9 (20.9) 68.4 (21.2) 68.3 (23.3) 0.98 (0.12) −0.18 (0.00) 0.77 (0.12)
PAI-BOR PUP 33.5 (15.7) 25.3 (12.3) 28.4 (14.9) 4.57* (0.06) 2.97** (0.58) −1.64 (0.23) 2.31* (0.33)
TAU 33.3 (13.2) 32.9 (12.9) 34.6 (11.3) 0.36 (0.03) −0.92 (0.14) −0.63 (0.11)
*p < .05; **p < .01; ***p < .001; ηp
2 = partial eta squared; BCAP=Brief Child Abuse Potential Inventory; PSI= Parenting Stress Index; DERS=Diﬃculties in
Emotion Regulation Scale; PAI-BOR=Personality Assessment Inventory-Borderline; DASS=Depression, Anxiety and Stress Scale.
1 Eﬀect size (ηp
2) interpreted as: small - 0.01; medium - 0.06; large - 0.14.
2 Eﬀect size (cohen’s d) interpreted as: small - 0.2; medium - 0.5; large - 0.8.
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recorded for 14 practitioners was 55 (SD=11.57) hours.
3.3. Statistical and clinical change on BCAP
As shown in Table 3, there was a decrease in BCAP scores for those
receiving the PuP program from baseline to 12-month follow-up (9.3 to
7.3) with an increase in scores for those receiving TAU (8.8 to 9.8).
Notably, 41% of those receiving TAU scored above the cut point for
Abuse Risk compared to 22% in the PuP program at the 12-month
follow-up. The intent-to-treat analysis found no signiﬁcant impact on
BCAP scores by group or time. However, there was a signiﬁcant time by
group interaction in which parents receiving PuP showed a decrease
and parents in the TAU group showed an increase in BCAP scores
(p < .03; Table 4). The per-protocol analysis found similar results with
a signiﬁcant time by group interaction and planned contrasts indicating
a reduction in BCAP scores at 6 and 12-months for those receiving the
PuP program (p < .01; medium eﬀect size; Table 5). There was a
clinically signiﬁcant increase in the proportion of parents who had re-
covered/improved and fewer who deteriorated in the PuP group com-
pared with those in TAU (p < 0.02; Table 6).
3.4. Analysis of change on secondary outcomes relating to parental emotion
regulation, mood and parenting stress and child outcome
The intent-to-treat analysis found a signiﬁcant interaction on emo-
tional regulation with a signiﬁcant improvement for those parents re-
ceiving the PuP program compared to those receiving TAU (p < .005).
There was a trend towards a signiﬁcant improvement in measures of
depression, anxiety and stress (p= .07). There were no signiﬁcant
diﬀerences in the two groups on measures of borderline psycho-
pathology or parenting stress (Table 5). A subsample of parents com-
pleted the BITSEA as many children were less than 12-months of age
and thus not within the age range for this measure. The per-protocol
analysis (Table 5) found signiﬁcant improvements on four of the ﬁve
secondary measures for those receiving the PuP program from baseline
to post-treatment (i.e., 6-months) and from baseline to ﬁnal follow-up
(12-months). While there were changes in parenting stress, this inter-
action did not reach statistical signiﬁcance (p= .06). There were no
signiﬁcant diﬀerences between the PuP group and TAU in children
classiﬁed as at risk on either problem scores or competence of the
BITSEA. The CARE-Index was coded on a subsample (PuP group = 21;
TAU= 19) when children were present at the post-treatment interview.
There were no diﬀerences between the groups (Supplementary Tables 1
and 2).
3.5. Economic evaluation
The mean (SE) total NHS and personal social service costs, inclusive
of the cost of the PUP program, were £18,931 (£2443) for those re-
ceiving the PuP program compared to £16,451 (£2241) for those re-
ceiving TAU, in parents with complete data, generating a mean cost
diﬀerence of £2480 (bootstrap 95% CI: -3906; £9156; p=0.457). The
incremental cost-eﬀectiveness of the PUP program, following multiple
imputation and bivariate seemingly unrelated regression of costs and
outcomes, is shown in Table 7 and Tables 8. The mean incremental cost-
eﬀectiveness of the PUP program was estimated at £34,095 per QALY
gained (Table 7) (If decision-makers are willing to pay £20,000 for an
additional QALY, the probability that the program is cost-eﬀective is
approximately 26.7%, increasing to 34.6% at a £30,000 cost-eﬀec-
tiveness threshold, a result that remained robust to sensitivity analyses.
When the BCAP measure was considered, the mean incremental cost-
eﬀectiveness of the PUP program was estimated at £1004 per unit
improvement in the BCAP (Table 8). The probability that the program is
cost-eﬀective is approximately 51.8% if decision-makers are willing to
pay £1000 for a unit improvement in the BCAP, increasing to 98.0% at
a £20,000 cost-eﬀectiveness threshold for this measure.
4. Discussion
The results of this pragmatic randomized controlled trial add to a
growing literature evaluating the eﬀectiveness and cost-eﬀectiveness of
parenting interventions in families who have a range of factors asso-
ciated with child abuse and neglect. The ﬁndings from the present study
provide converging evidence of improvements across primary and
many secondary outcomes. Signiﬁcant gains were found in child abuse
potential in the PuP program while those receiving TAU showed dete-
rioration at 12-months across both intent-to-treatment and per-protocol
analyses. The RCI showed signiﬁcant diﬀerences across the two groups:
30% of parents receiving the PuP program showed improvement
compared to 10% receiving TAU; 3% of those receiving the PuP pro-
gram showed signiﬁcant deterioration compared to 18% in TAU.
Comparison with the earlier trial of the PuP program (Dawe and
Harnett, 2007) showed a marked similarity in ﬁndings: 31% of parents
receiving the PuP program showed improvement compared to none
receiving standard care; conversely there were no parents who showed
deterioration in parents receiving the PuP program compared to 36%
receiving standard care. The deterioration in the TAU group raises
ongoing concerns about the future of the children in these families.
A range of measures was used to ascertain if diﬀerences in parental
emotional regulation were found in parents who received the PuP
program as this is proposed to be the key mechanism of change un-
derpinning the PuP program (Barlow et al., 2013; Harnett and Dawe,
2012). Parents receiving the PuP program showed signiﬁcant im-
provements in emotional regulation that measured constructs such as
engagement in goal-directed behaviors, impulse control and emotional
awareness for both the intent-to-treat analysis and the per-protocol
analysis. There were also substantial and signiﬁcant improvements on
measures of mood and borderline psychopathology in the per-protocol
analyses.
These results are consistent with accumulating evidence that par-
enting programs need to include an explict focus on the psychological
well-being of the parent when there is comorbid psychopathology and
parental substance misuse. The impact of the MIO program (Suchman
et al., 2017) on the sensitivity and reciprocity of mothers towards their
infants was attributed, in part, to the observation that the program,
delivered concomitantly with addiction treatment, addressed parental
emotion regulation challenges. Similarly, the Engaging Moms Program
(Dakof et al., 2010) included strategies to engage emotional and prac-
tical support from the mother’s family to assist the mother’s capacity to
cope with environmental adversities.
The results of the within-trial economic evaluation require careful
interpretation. The estimated ICER of £34,095 per additional QALY
translates into probabilities of cost-eﬀectiveness for the PUP program of
26.7% and 34.6% at cost-eﬀectiveness thresholds for an additional
QALY of £20,000 and £30,000, respectively (National Institute for
Health and Care Excellence, 2013). Although recommended for cost-
eﬀectiveness-based decision-making in the UK, our approach to QALY
measurement focused on parental health-related quality of life out-
comes and therefore is unlikely to have captured preferences for re-
ductions in child abuse potential or improvements in infant social and
emotional adjustment or parent-toddler interaction. When the BCAP
Table 6
Clinically signiﬁcant improvement and deterioration using Reliable Change
Index from baseline to 12 months.
RC + RC-
No change
Recovered/Improved Deteriorated
PuP 11 (30.6%) 1 (2.8%) 24 (66.7%)
TAU 4 (10.3%) 7 (17.9%) 28 (71.8%)
TAU Treatment as usual; p< .02.
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measure was selected as the primary measure of consequence, the
economic evaluation generated probabilities of cost-eﬀectiveness as
high as 98.0% depending on the value of the cost-eﬀectiveness
threshold for a unit improvement in the BCAP. A recent stated pre-
ference study estimated a general US population willingness to pay of
$175 for a 1 in 100,000 reduction in the risk of child maltreatment-
related mortality (Corso et al., 2013). However, in the absence of em-
pirical evidence from longitudinal studies exploring the relationship
between unit changes in the BCAP and long-term risk of child mal-
treatment-related mortality, we are unable to use this or indeed any
other external evidence to value societal preferences for the reduction
in the BCAP score generated by the PUP program. Nonetheless, the
probability that the program is cost-eﬀective is approximately 51.8% if
decision-makers are willing to pay £1000 for a unit improvement in the
BCAP, increasing to 98.0% at a £20,000 cost-eﬀectiveness threshold for
this measure. This suggests that the PuP program is likely to be cost-
eﬀective with relatively little investment as the economic value asso-
ciated with the reduction in child abuse potential is likely to outweigh
the relatively small increase in economic cost.
This pragmatic trial compared TAU with the PuP program delivered
by practitioners to families engaged in substance misuse treatment
services. There are a number of limitations that need to be considered.
The ﬁrst relates to the delivery of the PuP program. Practitioners re-
ceived supervision, the program was detailed in a Therapist Manual and
accompanying Parent Workbook and independent clinical ﬁle audits
were conducted. However, the actual quality of the delivery of the in-
tervention was not measured. This is typically undertaken in treatment
studies by recording sessions and having ratings of adherence to
treatment protocols independently rated. While there are challenges
associated with recording during home visits, particularly for popula-
tions with substance misuse problems, future research could revisit this
issue. Second, there was a range of community-based addiction services
supporting parents. There is likely to be variability in the quality and
nature of the treatment provided which, in turn, may have inﬂuenced
outcomes. Finally, the primary outcome measure was the parent report
of child abuse potential. While there is considerable evidence sup-
porting the validity of this measure (see Milner et al., 2017, for a re-
view), administrative data from child protection records would have
provided important additional information.
4.1. Concluding comments
Like many randomized controlled trials, recruitment was slower and
resulting group sizes smaller than anticipated (McDonald et al., 2006).
Despite a range of recruitment-promoting activities, including close
liaison with key practitioners who served as gatekeepers, there were
ongoing concerns raised by referral agencies about conducting an RCT
in which a potentially eﬀective treatment was being withheld to a
vulnerable population (Borschmann et al., 2014). In contrast, once re-
cruited, there was a high acceptance rate by study participants in both
arms of the trial. While a per-protocol analysis potentially over-
estimates treatment eﬀects (Nam and Toneatto, 2016), an intent-to-
treat analysis has been criticized for being too cautious and thus more
susceptible to type II error (Fergusson et al., 2002). Conducting both is
recommended given power and attrition considerations (ICH
Harmonised Tripartite Guidelines, 1998).
In conclusion, the current study was able to demonstrate both ac-
ceptability of the trial protocol to participants, high retention in a
treatment protocol for those allocated to the PuP program and sig-
niﬁcant reduction in child abuse potential for those receiving the PuP
program across a range of analytic strategies. Improvements in parental
emotional regulation for those receiving the PuP program are also
consistent with the proposed mechanism of change underlying the
program logic.
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